A strategy for oligonucleotide microarray probe reduction

Genome Biol. 2002;3(12):RESEARCH0073. doi: 10.1186/gb-2002-3-12-research0073. Epub 2002 Nov 25.

Abstract

Background: One of the factors limiting the number of genes that can be analyzed on high-density oligonucleotide arrays is that each transcript is probed by multiple oligonucleotide probes. To reduce the number of probes required for each gene, a systematic approach to choosing the most representative probes is needed. A method is presented for reducing the number of probes per gene while maximizing the fidelity to the original array design.

Results: The methodology has been tested on a dataset comprising 317 Affymetrix HuGeneFL GeneChips. The performance of the original and reduced probe sets was compared in four cancer-classification problems. The results of these comparisons show that reduction of the probe set by 95% does not dramatically affect performance, and thus illustrate the feasibility of substantially reducing probe numbers without significantly compromising sensitivity and specificity of detection.

Conclusions: The strategy described here is potentially useful for designing small, limited-probe genome-wide arrays for screening applications.

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Cerebellar Neoplasms / classification
  • Cerebellar Neoplasms / genetics
  • Cerebellar Neoplasms / mortality
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / metabolism
  • Expressed Sequence Tags
  • Genes, Neoplasm / genetics
  • Humans
  • Leukemia, Myeloid / classification
  • Leukemia, Myeloid / genetics
  • Lymphoma, B-Cell / classification
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / mortality
  • Lymphoma, Large B-Cell, Diffuse / classification
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Medulloblastoma / classification
  • Medulloblastoma / genetics
  • Medulloblastoma / mortality
  • Nucleic Acid Probes / metabolism*
  • Oligonucleotide Array Sequence Analysis / methods*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / classification
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Predictive Value of Tests

Substances

  • DNA, Neoplasm
  • Nucleic Acid Probes